Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
暂无分享,去创建一个
T. Chatila | A. Sharkey | T Chatila | V Raman | J Kim | A Sharkey | V. Raman | Jennifer M. Kim | A. Sharkey | J. Kim
[1] J. Newburger,et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. , 1998, The Pediatric infectious disease journal.
[2] M Takahashi,et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. , 1991, The New England journal of medicine.
[3] S. Koike,et al. Kawasaki disease: effect of treatment on coronary artery involvement. , 1979, Pediatrics.
[4] J. Newburger,et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. , 1996, The Journal of pediatrics.
[5] T. Kamiya,et al. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. , 1982, Japanese circulation journal.
[6] R. Geha,et al. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. , 1986, The Journal of clinical investigation.
[7] M. Haubitz,et al. Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] D. Morens,et al. Kawasaki disease: a 'new' pediatric enigma. , 1978, Hospital practice.